Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 9, 2022
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
Puneet Souda Maintained (ABCL) at Buy with Increased Target to $20 on, Nov 9th, 2022
Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Increased Target from $13 to $20 on, Nov 9th, 2022.
Puneet has made no other calls on ABCL in the last 4 months.
There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Puneet
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $34 on, Wednesday, August 10th, 2022
- Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $22 on, Tuesday, July 26th, 2022
